|
Volumn 53, Issue 6, 2004, Pages 601-604
|
Study of thromboxane A 2 antagonist reduction in the treatment of patients with perennial allergic rhinitis
|
Author keywords
Allergic rhinitis; Eosinophil; Ramatroban; Reduction; Thromboxane A 2
|
Indexed keywords
RAMATROBAN;
THROMBOXANE A2;
THROMBOXANE A2 RECEPTOR BLOCKING AGENT;
CARBAZOLE DERIVATIVE;
SULFONAMIDE;
THROMBOXANE A2 RECEPTOR;
ADULT;
ALLERGIC RHINITIS;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DRUG DOSE REDUCTION;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG UTILIZATION;
EOSINOPHILIA;
FEMALE;
HUMAN;
MALE;
NOSE CONGESTION;
NOSE SMEAR;
OUTCOMES RESEARCH;
PERENNIAL RHINITIS;
RHINORRHEA;
SNEEZING;
SYMPTOM;
DRUG ANTAGONISM;
ADULT;
CARBAZOLES;
FEMALE;
HUMANS;
MALE;
RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2;
RHINITIS, ALLERGIC, PERENNIAL;
SULFONAMIDES;
|
EID: 3242789542
PISSN: 00214884
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (11)
|